AFG
DFTX

Albion Financial Group’s Definium Therapeutics DFTX Stock Holding History

Albion Financial Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-132
Closed -$752 – 692
2024
Q3 		$752 Hold
132
– – ﹤0.01% 466
2024
Q2 		$952 Hold
132
– – ﹤0.01% 461
2024
Q1 		$1.24K Hold
132
– – ﹤0.01% 440
2023
Q4 		$484 Sell
132
-191
-59% -$575 ﹤0.01% 448
2023
Q3 		$1.01K Hold
323
– – ﹤0.01% 416
2023
Q2 		$1.15K Hold
323
– – ﹤0.01% 407
2023
Q1 		$1.02K Hold
323
– – ﹤0.01% 403
2022
Q4 		$711 Hold
323
– – ﹤0.01% 444
2022
Q3 		$1K Sell
323
-2
-0.6% -$19 ﹤0.01% 417
2022
Q2 		$3K Hold
325
– – ﹤0.01% 391
2022
Q1 		$5K Hold
325
– – ﹤0.01% 414
2021
Q4 		$7K Hold
325
– – ﹤0.01% 430
2021
Q3 		$11K Hold
325
– – ﹤0.01% 364
2021
Q2 		$17K Buy
+325
New +$17.1K ﹤0.01% 344

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Albion Financial Group's DFTX Position: Q4 2024 in Review

Albion Financial Group sold out of Definium Therapeutics (DFTX) in Q4 2024, closing a stake of 132 shares — an estimated $752 sold.

Albion Financial Group first reported a position in DFTX in Q2 2021 and held it in 14 quarters. The position peaked at $17K in Q2 2021. 172 funds tracked by Wall St. Rank hold DFTX as of Q4 2024.

  • Albion Financial Group reported no remaining Definium Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Albion Financial Group sold 132 Definium Therapeutics shares in Q4 2024, an estimated $752.
  • Albion Financial Group first reported a position in Definium Therapeutics in Q2 2021 and held it in 14 quarters.
  • Albion Financial Group's Definium Therapeutics position peaked at $17K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2024.

Based on Albion Financial Group's 13F filing for Q4 2024, filed 17 Jan 2025.